Abstract:Abstract Background Appropriate passive-active immunoprophylaxis effectively reduces mother-to-child transmission (MTCT) of hepatitis B virus (HBV), but the immunoprophylaxis failure was still more than 5% under the current strategy. The study objective was to investigate the effects of high dose of HB vaccine on MTCT and immune response for infants born to hepatitis B surface antigen (HBsAg)-positive mothers. Methods This was a prospective, multicenter, large-sample cohort study in four sites of China, and 955 pairs of HBsAg-positive mothers and their infants were enrolled in our investigation. The infants were given 10 μg or 20 μg HB vaccine (at age 0, 1, and 6 months) plus HB immunoglobulin (at age 0 and 1 month). Serum HBsAg, antibody to HBsAg (anti-HBs), and/or HBV DNA levels in the infants were determined at age 12 months. The safety of 20 μg HB vaccine was evaluated by adverse events and observing the growth indexes of infants. Results Thirteen of 955 infants were HBsAg-positive at 12 months. Stratification analysis showed that immunoprophylaxis failure rates in the 20 μg group were not significantly different from the 10 μg group, whatever maternal HBV load was high or not. But the high dose of HB vaccine significantly reduced low-response rate (anti-HBs 10–100 IU/L) ( P = 0.002) and middle-response rate (anti-HBs 100–1000 IU/L) ( P = 0.022) and improved high-response rate (anti-HBs ≥ 1000 IU/L) ( P < 0.0001) in infants born to mothers with HBV DNA < 5 log 10 IU/mL. For infants born to mothers with HBV DNA ≥ 5 log 10 IU/mL, 20 μg HB vaccine did not present these above response advantages. The 20 μg HB vaccine showed good safety for infants. Conclusions The 20 μg HB vaccine did not further reduce immunoprophylaxis failure of infants from HBsAg-positive mothers, but increased the high-response and decreased low-response rates for infants born to mothers with HBV DNA < 5 log 10 IU/mL. Trial registration Chinese Clinical Trial Registry, ChiCTR-PRC-09000459

Algebraic scattering theory for heavy ions.

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

The effects of increased dose of hepatitis B vaccine on mother-to-child transmission and immune response for infants born to mothers with chronic hepatitis B infection: a prospective, multicenter, large-sample cohort study

No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg

What to do with non-replanted hands?

HLA gene polymorphisms and long-term humoral response in children immunized with hepatitis B vaccine at birth

Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study

Minimal Association of Alleles of Human Leukocyte Antigen Class Ii Gene and Long-Term Antibody Response to Hepatitis B Vaccine Vaccinated During Infancy

Immune Response to Hepatitis B Vaccine in Children Born to HBsAg Positive Mothers: a Meta-Regression Analysis

Shift-effect in the rabbit retinal ganglion cells

Revaccination of Non- and Low- Responders after a Standard Three Dose Hepatitis B Vaccine Schedule

Impaired trophoblast Toll-Like Receptor 3 signaling pathway involves in hepatitis B vaccine non- or hypo-response of infants born to HBsAg-positive mothers

Genetic Effects Have a Dominant Role on Poor Responses to Infant Vaccination to Hepatitis B Virus

Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan

Association of Polymorphisms of Cytokine and Tlr-2 Genes with Long-Term Immunity to Hepatitis B in Children Vaccinated Early in Life

Cytokine IL-5 and HGF: combined prediction of non-/low immune response to hepatitis B vaccination at birth in infants born to HBsAg-positive mothers

Association of Cytokine Gene Polymorphisms with Long-Term Humoral Response in Children Vaccinated Against Hepatitis B in Infancy

Immunogenicity of Hepatitis B Vaccine in Preterm or Low Birth Weight Infants: A Meta-Analysis

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.

Strategies for Hepatitis B Booster Vaccination among Children: an 8-Year Prospective Cohort Study

Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine.